Table 1.
Population characteristic | Number | Data source (reference) |
---|---|---|
Total population, 2020 | 45,741,000 | Worldometers 36 |
Women aged 15–49 years | 10,939,000 | Worldometers 36 |
Children (5–14 years) | 13,252,128 | Worldometers 36 |
Adults | 24,693,000 | Worldometers 36 |
Persons living with HIV | 1,400,000 | UNAIDS, 2020 28 |
Children living with HIV | 100,000 | UNAIDS, 2020 |
HIV patients on ART | 1,300,000 | UNAIDS, 2020 |
AIDS-related deaths | 22,000 | UNAIDS, 2020 |
Pulmonary tuberculosis | 85,500 | WHO, 2020 29 |
COPD prevalence | 16.2% age > 30 years; 4.1% of population | van Gemert et al. 25 |
Asthma rates in adults and adolescents | 12.3% (9.1–15.5) | Kirenga et al.20,21 |
Lung cancer/year | 486 | Globocan 35 |
Acute myelogenous Leukemia/year | 1372 | Globocan 35 ; Natukunda et al. 29 |
ICU beds nationally | 55 (pre-COVID-19) | Atumanya et al. 34 |
Abdominal surgeries/year | 3000 | Estimate |
ART, anti-retroviral therapy; COPD, chronic obstructive pulmonary disease; COVID-19, coronavirus disease 2019; Globocan, Global Cancer Observatory; ICU, intensive care unit; UNAIDS, The Joint United Nations Programme on HIV/AIDS.